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Type 2 diabetes mellitus (T2DM) and aging are char-
acterized by insulin resistance and impaired mito-
chondrial energetics. In lower organisms, remodeling
by the protease pcp1 (PARL ortholog) maintains the
function and lifecycle of mitochondria. We examined
whether variation in PARL protein content is associ-
ated with mitochondrial abnormalities and insulin
resistance. PARL mRNA and mitochondrial mass
were both reduced in elderly subjects and in subjects
with T2DM. Muscle knockdown of PARL in mice
resulted in malformed mitochondrial cristae, lower
mitochondrial content, decreased PGC1a protein
levels, and impaired insulin signaling. Suppression
of PARL protein in healthy myotubes lowered mito-
chondrial mass and insulin-stimulated glycogen
synthesis and increased reactive oxygen species
production. We propose that lower PARL expression
may contribute to the mitochondrial abnormalities
seen in aging and T2DM.INTRODUCTION
Type 2 diabetes mellitus (T2DM) is the most common metabolic
disease in the elderly (King et al., 1998) and is one of the leading
causes of death in the U.S. (Marx, 2002). T2DM is projected to
afflict more than 300 million individuals worldwide by the year
2025 (Zimmet et al., 2001). Although the primary cause of T2DM
is unknown, it is clear that insulin resistance in skeletal muscle
and liver plays a primary role in its pathogenesis before the
progressive failure of pancreatic b cells (Lillioja et al., 1993).
Studies of the etiology of insulin resistance in skeletal muscle412 Cell Metabolism 11, 412–426, May 5, 2010 ª2010 Elsevier Inc.have implicated numerous factors including reduced mitochon-
drial mass (Kelley et al., 2002), lower mitochondrial oxidative
phosphorylation (Befroyetal., 2007;Petersenetal., 2005),blunted
lipid oxidation (Zhang et al., 2007), and elevated reactive oxygen
species (ROS) production (Civitarese et al., 2006; Patti et al.,
2003; Petersen et al., 2004; Ukropcova et al., 2007). However,
themolecularmechanism(s) governingmitochondrial dysfunction
and insulin resistance in skeletal muscle are not completely
understood.
Mitochondria carry out a vast array of cellular functions,
including ATPproduction, biosynthesis of amino acids and lipids,
cytosolic calcium transport (Frazier et al., 2006), and amplifica-
tion of apoptotic stimuli (Cipolat et al., 2004). Part of the functional
diversity and variability in mitochondrion ultrastructure is
mediated by the interaction with the cytoskeleton (Hollenbeck
and Saxton, 2005) and the balance between the forces of mito-
chondrial fusion and fission. In lower organisms, mitochondrial
fusion is regulated, in part, by the evolutionary conserved
GTPase protein mgm1 (Herlan et al., 2003), the human ortholog
of which is optic atrophy 1 (OPA1). Mutations in the OPA1 gene
are the most common cause of autosomal-dominant optic
atrophy in humans (Alexander et al., 2000), a progressive disease
of the retinal ganglion. Mgm1/OPA1 participates in several bio-
logical processes, most notably fusion of the inner mitochondrial
membrane, remodeling of the mitochondrial cristae (Cipolat
et al., 2004), inhibition of cytochrome c release, and apoptosis
(Cipolat et al., 2006). In budding yeast (McQuibban et al., 2003)
and in mice (Cipolat et al., 2006) mgm1, is cleaved by the
inner mitochondrial membrane rhomboid protease, pcp1. Yeast
strains lacking pcp1 exhibit decreased oxidative capacity,
impaired growth, and fragmented mitochondria (McQuibban
et al., 2003; Sesaki et al., 2003). Importantly, insertion of the
human ‘‘presenilin-associated rhomboid-like’’ (PARL) gene (the
pcp1 human ortholog) into pcp1-deficient yeast rescues growth
and restores mitochondrial morphology, suggesting that PARL
may play a similar role in humans (McQuibban et al., 2003).
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Figure 1. Human mRNA Expression and
Rodent Tissue Distribution
(A and B) Presenillin-associated rhomboid-like
(PARL) mRNA and mitochondrial content by
mtDNA copy number (mtDNA) in lean-young
(n = 11) and lean-insulin-resistant elderly subjects
(n = 11) and participants with type 2 diabetes mel-
litus (T2DM) (n = 32). Data represent mean ± SEM.
(C) Western analyses with affinity-purified anti-
PARL antibodies in Psammomys obesus. PARL
protein expression is most abundant in tissues
that rely heavily on oxidative metabolism (top).
PARL protein expression is greater in muscle
groups, including soleus and the red gastrocne-
mius, that contain a higher proportion of oxidative
fibers (bottom). Polyclonal antisera were gener-
ated using a KLH-conjugated peptide corre-
sponding to amino acids 53–77 of human PARL.
PARL-specific antibodies were affinity purified
using GST-PARL (53–77).
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Muscle Insulin Resistance and MitochondriaWe have previously shown that PARL mRNA is reduced in
skeletal muscle of obese diabetic Psammomys obesus and is
positively correlated with insulin sensitivity in humans (Walder
et al., 2005). Given the large body of accumulating evidence
from the past decade demonstrating impaired mitochondrial
energetics in states of insulin resistance, we hypothesized that
dysregulation of PARL contributes to the defective lipid and
glucose metabolism frequently seen in T2DM and aging.
RESULTS
PARL mRNA Is Associated with Reduced Mitochondrial
Mass in T2DM and Aging
To investigate whether variation in PARL mRNA expression was
associated with mitochondrial dysfunction and insulin resistance
in humans, we studied healthy, young individuals (23 ± 1 years
old; n = 11) and older subjects (64.4 ± 1.2 years old; n = 11)
matched for body composition, plasma-free fatty acids, and
glucose concentrations, as well as physical activity levels (Table
S1 available online). Relative to younger participants, elderly
individuals had elevated plasma insulin (p < 0.01), lower insulinCell Metabolism 11, 412sensitivity (p < 0.01), and a 19% reduction
in resting metabolic rate (RMR; p < 0.01)
(Table S1). Analysis of the skeletal mus-
cle transcriptome from muscle biopsies
collected under fasting conditions re-
vealed lower mRNA content of peroxi-
some proliferator-activated receptor g
coactivator b (PGC1b), nuclear respira-
tory factor (NRF1), and mitochondrial
transcription factor A (TFAM) in elderly
individuals compared to young controls,
suggesting a reduction in mitochondrial
number and function (Table S2). Con-
sistent with these observations, PARL
mRNA, mtDNA (Figures 1A and 1B), and
citrate synthase activity (Table S2) (the
latter two being markers of mitochondrialcontent; Wang et al., 1999) were reduced in elderly subjects by
51%, 48%, and 33%, respectively (all p < 0.05). In addition,
PARLmRNAwas strongly correlated with TFAMmRNA (r = 0.87;
p < 0.001) and mtDNA content (r = 0.61; p = 0.001), suggesting
that PARL may be involved in the regulation of mitochondrial
mass.
Functional studies by Petersen et al. (2003) and Conley et al.
(2007) have observed reduced resting rates of ATP synthesis in
elderly subjects with insulin resistance, suggesting that mito-
chondrial dysfunction with aging may be relevant to mitochon-
drial dysfunction seen in T2DM (Petersen et al., 2005). We
therefore next identified that PARL mRNA and mtDNA content
were reduced in subjects with T2DM relative to lean healthy
controls (Figures 1A and 1B; p < 0.05) and in Pima Indians with
a family history of T2DM (FH+; n = 14) compared to those without
a family history (FH; n = 7) (50 ± 6 versus 86 ± 15 PARL mRNA/
cyclophilin mRNA; p = 0.05). Collectively, these observations
establish that PARL mRNA and mitochondrial content in skeletal
muscle are reduced in subjects with a genetic predisposition to
develop T2DM, those presenting with T2DM, and in insulin-resis-
tant elderly individuals.–426, May 5, 2010 ª2010 Elsevier Inc. 413
Cell Metabolism
Muscle Insulin Resistance and MitochondriamCK-CAR-PARL() Transgenic Mice Have Reduced
Mitochondrial Mass in Muscle
Tissues with high demand for aerobic respiration, such as the
brain, skeletal muscle, and heart, have the most prominent
requirement for mitochondrial reticulum networks (Bach et al.,
2003; Kirkwood et al., 1986). Accordingly, in Psammomys
obesus, PARL protein was highly expressed in the brain, heart,
and skeletal muscle and predominantly in oxidative muscle
fibers of lean healthy animals (Figure 1C). Similarly, in humans,
PARL mRNA is mainly expressed in skeletal muscle, brain,
placenta, testis, and heart (Figure S1A). Given that skeletal
muscle is the major site of insulin-stimulated glucose disposal
and, therefore, a key tissue in the development of whole-body
insulin resistance (Petersen et al., 2005), we set out to examine
the functional consequences of reduced PARL protein on mito-
chondrial function and glucose metabolism in the skeletal
muscle of a transgenic rodent model.
Mice expressing the human coxsackie/adenovirus receptor
(CAR) under the control of the muscle creatine kinase promoter
(mCK) were used to create mCK-CAR-PARL() mice muscle,
herein referred to as PARL() mice. mCK-CAR mice have a
dramatic enhancement of skeletal muscle transduction with
site-specific injections of AdV-shuttle because they transgeneti-
cally overexpress CAR on mature myofibers (Nalbantoglu et al.,
2001). We treated mCK-CAR mice (16 weeks of age; n = 7) with
a single intramuscular transverse injection into each lobe of
the gastrocnemius (gastroc) and tibialis anterior/extensor digito-
rum longus (TA/EDL) muscle groups with AdV-PARL() siRNA
injected into the left leg and an ‘‘empty’’ vector with a GFP
expression cassette in the right leg to serve as a collateral control
(Figure S1B). Analysis of PARL expression in the TA/EDL muscle
of the PARL() leg revealed lower PARL protein that was
associated with reduced PGC1a and CS protein levels relative
to the control leg (mCK-GFP) (Figure 2A). Similar reductions in
PARL protein were observed in gastrocmuscle (data not shown).
MtDNA (Figure 2D; p = 0.03) content and CS activity (Figure 2E;
p = 0.007) were lower in PARL() muscle relative to GFP control
muscle. Thus, it appears that mitochondrial content is affected
by PARL protein content in muscle.
The key regulators of mitochondrial fusion, mitofusin 1 and 2
(Mfn1/2) and OPA1 (long and short isoform of OPA1; Guillery
et al., 2008) were examined next. MFN2 and OPA1 were lower
in PARL() muscle, whereas MFN1 was unchanged (Figure 2A).
The reductions in OPA1 protein are consistent with previous
reports demonstrating enhanced degradation of OPA1 protein
(constitutive cleavage) and increased susceptibility to apoptosis
(Cipolat et al., 2006; Griparic et al., 2007) with reduced PARL and
DRP-1 (Mopert et al., 2009) expression. Therefore, lower OPA1
protein may result from reduced mitochondrial mass or dysfunc-
tion as observed in PARL loss-of-functionmyotubes (see below).
OPA1 functions include mitochondrial fusion and mitochondrial
cristae remodeling (Cipolat et al., 2006; Griparic et al., 2007).
To determine the effects of PARL depletion on cellular
morphology, we examined mCK-CAR mice muscle by transmis-
sion electron microscopy. Electron micrographs demonstrated
normal mitochondrial distribution (Figures 3A and 3B) in both
PARL() and GFP mice muscle; however, in PARL() muscle
(Figure 3C), mitochondrial cristae appeared ‘‘disorganized,’’
with some mitochondria totally lacking clearly defined cristae.414 Cell Metabolism 11, 412–426, May 5, 2010 ª2010 Elsevier Inc.This mitochondrial phenotype is characteristic of HeLa cells
(Griparic et al., 2007) and ‘‘class II’’ remodeled mitochondria
from mouse embryonic fibroblasts depleted of OPA1 (Frezza
et al., 2006). We also observed increased activity of the pro-
apoptotic protein caspase-9 in PARL() TA/EDL muscle (1.8 ±
0.4 versus 2.9 ± 0.6 rfu/mg protein; p = 0.048), consistent with
a role for PARL in the antiapoptotic function of OPA1 (Frezza
et al., 2006). Of interest, global PARL knockout mice display
normal intrauterine development but from the fourth postnatal
week undergo progressive multisystemic atrophy leading to
accelerated cellular apoptosis and cachectic death (Cipolat
et al., 2006). Skeletal muscle loss and the development of sarco-
penia is a hallmark feature of the aging process and is associated
with elevated levels of apoptosis (Whitman et al., 2005), suggest-
ing that lower PARL protein may be a contributing factor to
muscle atrophy during aging.
The inner mitochondrial membrane cristae are easily
damaged by ROS as a large portion of protein complexes
associated with oxidative phosphorylation are embedded in
this membrane (Gilkerson et al., 2003). Analysis of cysteine
oxidation was performed by measuring protein disulfides and
TBARS concentration (marker of lipid peroxidation) in PARL()
muscle and revealed elevated oxidative damage relative to the
control muscle (Figures 2F and 2G; p < 0.05). Superoxide dis-
mutase (SOD) catalyzes the dismutation of superoxide radicals
into hydrogen peroxide and oxygen and is considered to be
one of the primary antioxidant responses to elevated ROS
production (Luo et al., 2006). SOD protein was elevated in the
muscle of PARL() muscle when compared to control muscle,
whereas there was no difference in glutathione peroxidase
content (Figure 2A). Thus, PARL protein appears to influence
OPA1 protein levels, and a low level of PARL protein expres-
sion is associated with increased oxidative damage in skeletal
muscle. Importantly, reduced muscle PARL protein content
results in abnormal mitochondrial morphology, consistent with
the mitochondrial structural abnormalities observed in skeletal
muscle of subjects with T2DM (Kelley et al., 2002; Ritov
et al., 2005).
PARL() Mouse Muscle Has Elevated Lipid Content
and Impaired Insulin Signaling
Insulin-resistant individuals have excess triglyceride and intra-
myocellular lipid (IMCL) accumulation (Forouhi et al., 1999;
Jacob et al., 1999; Krssak et al., 1999; Perseghin et al., 1999)
in skeletal muscle (Goodpaster et al., 2000a, 2000b; Pan et al.,
1997) that has been postulated to accumulate, in part, due to
deficient mitochondrial oxidative capacity (Befroy et al., 2007;
McGarry, 1992; Morino et al., 2005; Petersen et al., 2003,
2005; Zhang et al., 2007). We next measured the triglyceride
content in PARL() mice muscle homogenates. PARL() muscle
had elevated triglyceride content relative to the GFP null muscle,
although this did not reach significance (65 ± 15 versus
48 ± 9 mM/mg protein; p = 0.077). Several groups have shown
that the accretion of long-chain fatty acyl-CoAs (LCFCoA), diac-
ylglycerols (DAG), and ceramides (Adams et al., 2004, 2009;
Chavez and Summers, 2003; Yu et al., 2002) is more closely
associated with impaired insulin signaling than triglycerides or
IMCL per se. Among these bioactive lipid intermediates, there
is evidence to support a direct role for fatty acyl CoAs in the
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Figure 2. mCK-PARL() Mice Muscle
Molecular characterization of 12-week-old mice expressing the human coxsackie/adenovirus (CAR) receptor under the control of the muscle creatine kinase
promoter (mCK) treated with either adenovirus (AdV)-GFP-empty cassette control in the left muscle and AdV-PARL-siRNA in the collateral leg to create
mCK-CAR-PARL(-) muscle.
(A) Total amount of PARL, peroxisome proliferative-activated receptor g coactivator 1 a (PGC1a), citrate synthase (CS), optic atrophy 1 (OPA1), Mitofusin 1 (Mfn1),
mitofusin 2 (Mfn2), fission 1 (Fis1), superoxide dismutase 2 (SOD2), glutathione peroxidase 1 (GPx1) and b-actin protein in the AdV-GFP and PARL() muscles.
(B) Phosphorylation and total amount of protein of key insulin-signaling cascade proteins in AdV-GFP and PARL() muscles in the fasting (top) and insulin-stim-
ulated condition (bottom).
(C) Total amount of insulin receptor b (IRb) and GLUT4 protein in the plasma membrane fraction of AdV-GFP and PARL() muscles.
(D and E) MtDNA (D) and citrate synthase (CS) activity (E) in AdV-GFP and PARL() muscles.
(F) Measurements of irreversible cysteine oxidation using dithiothreitol-reducible cysteines with 6-iodoacetimido-fluorescein. A low value equates to elevated
rates of irreversible cysteine oxidation, whereas a high value implies a very low level of cysteine oxidation.
(G) Measurement of thiobarbituric acid (TBA)-reactive substances for estimate of muscle lipid peroxidation.
(H) Measurement of long-chain fatty acyl-CoA using high-performance liquid chromatography. Total amount of saturated long-chain fatty acyl-CoAs (p = 0.16),
myristoyl-CoA (14:0; p = 0.031), arachidonoyl-CoA (20:4; p = 0.25), palmitoyl-CoA (16:0; p = 0.016), oleoyl-CoA (18:1; p = 0.17), stearoyl-CoA (18:0; p = 0.004), and
arachidoyl-CoA (20:0, p = 0.4) in GFP and PARL() muscle.
(A–E) and (H) n = 6; (F and G) n =5. (D–G) Data represent mean ± SEM. *p < 0.05.
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Muscle Insulin Resistance and Mitochondriaresistance to insulin action (Adams et al., 2004; Chavez and
Summers, 2003; Yu et al., 2002). Consistently, knockdown of
PARL protein in skeletal muscle resulted in increased concentra-
tion of all fatty acyl CoAs examined (Figure 2H, total fatty aycl
CoAs). In particular, the saturated long-chain myristoyl-CoA
(14:0; p = 0.031), palmitoyl-CoA (16:0; p = 0.016), and stearoyl-
CoA (18:0; p = 0.004) were all elevated in PARL() muscle rela-
tive to the collateral GFP control.
We then tested whether elevated LCFCoA concentration in
PARL() muscle was associated with impaired insulin signaling.
Animal models and in vitro experiments have shown that theCphosphorylation of serine residues (307, 636, 639, and 1101) of
insulin-receptor substrate-1 (IRS-1) blocks the activity of IRS-1
on critical tyrosine sites that are required for phosphatidylinositol
3-kinase (PI3K) activation (at phosphorylation site PI3K p85-
Tyr458; Luo et al., 2007; Yi et al., 2007). Downstream of PI3K,
Akt phosphorylation at Ser473 has been shown to be a key
step for the activation of glucose transport in skeletal muscle
(Morino et al., 2005). In fasting conditions, we observed reduced
basal phosphorylation of PI3K-Tyr458 and AKt-Ser473 in PARL()
TA/EDL muscle relative to control muscle (Figure 2B). In the
insulin-stimulated state, phosphorylation at IRS-1Ser-1101 wasell Metabolism 11, 412–426, May 5, 2010 ª2010 Elsevier Inc. 415
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Figure 3. Mitochondrial and Cellular Imaging
(A–D) Representative transmission electron microscopy of cross-sectional slice of AdV-GFP (A and C) and PARL() (B and D) muscles at low (34000, top two
images) and high (320,000, bottom two images) magnification are shown.
(E–H) Effects of PARL protein depletion onmitochondrial distribution in primary skeletal muscle cells derived from lean-young subjects and transducedwith AdV-
GFP control and AdV-PARL-siRNA.
(E and F) Wet-scanning electron microscopy analysis of AdV-GFP-depleted (E) and AdV-PARL()-depleted (f) myotubes. N, nucleus. Scale bar, 5 mm.
(G andH)Mitochondrial distribution in AdV-GFP (G) and AdV-PARL() (H) myotubesmeasured usingMTG. Respiringmyotubes were incubated with 100 nMMTG
for 30 min.
Images were acquired within 5 min using a conventional wide-field microscope fitted with a 340 Nikon plan-apo objective. n = 4.
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Muscle Insulin Resistance and Mitochondriaelevated in PARL() muscle relative to control, in parallel with
lower insulin-stimulated Akt-Ser473 phosphorylation (Figure 2B).
We next isolated the cytosolic and plasma membrane fraction
of PARL() and AdV-GFP red (oxidative) gastrocnemius muscle
under insulin-stimulated conditions. No change was observed in
the plasma membrane content of the insulin receptor-b between
PARL) and GFP control muscle (Figure 2C). However, reduc-
tions in muscle PARL protein resulted in lower insulin-stimulated
translocation of GLUT4 protein to the plasma membrane
(Figure 2C). Together, these data indicate that skeletal muscle-
specific reduction of PARL protein results in elevated saturated
long-chain fatty acyl CoAs, impaired insulin signaling, and
reduced GLUT4 translocation to the plasma membrane.
HFD Lowers Muscle PARL and PGC1amRNA,
along with Glucose Tolerance in Mice
Impairments in mitochondria transcription and function (Civitar-
ese et al., 2006; Patti et al., 2003; Petersen et al., 2004), along
with lower PARL mRNA (see above), are present in the predia-
betic state, suggesting that PARL and mitochondrial abnormali-
ties may be primary factors in the development of skeletal
muscle insulin resistance. Because a high-fat diet (HFD) causes
insulin resistance and a decrease in the expression of multiple416 Cell Metabolism 11, 412–426, May 5, 2010 ª2010 Elsevier Inc.genes involved in mitochondrial biogenesis and oxidative
phosphorylation (Koves et al., 2008; Sparks et al., 2005, 2006;
Tunstall and Cameron-Smith, 2005), we examined whether the
regulation of PARL transcription precedes or coincides with
changes in glucose tolerance, mtDNA, fusion, and fission gene
expression in C57Bl6/J mice fed a HFD for 4 or 10 weeks. After
4 weeks of the HFD, there was no difference in fasting glucose
levels between groups; however, blood glucose levels were
significantly elevated in mice fed a HFD for 10 weeks (Table
S3; p < 0.05). By 4 weeks, HFD mice had glucose intolerance
and resistance to the glucose-lowering effects of insulin that
worsened by the end of the study (Table S3). Glucose homeo-
stasis remained normal in control diet mice.
Despite the insulin resistance in HFD mice, there was no
change in the expression of the majority of genes examined at
4 weeks (Table S3). DRP1 was the only gene modified, with an
upregulation in HFD group (Table S3; p < 0.05). The increase in
DRP1 expression in the HFD mice may relate to the role of
DRP1 in the tethering and biogenesis of peroxisomes (Koch
et al., 2003) that participate in the b oxidation of fatty acids and
the adaptation to nutritional stimuli that elevates lipid flux (Reddy
andMannaerts, 1994). After 10weeks of HFD, therewas a down-
regulation in mtDNA that wasmirrored by a suppression of PARL
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Figure 4. Human Myotubes
(A) PARL protein expression and key proteins of mitochondrial fusion (MFN1 and -2 and OPA1); mitochondrial fission, human fission 1 (FIS1) and dynamin-related
GTPase 1 (DRP1); mitochondrial energetics, citrate synthase (CS); and silent mating type information regulation 2 homolog 1 (SIRT1).
(B) Mitochondrial content assessed by mtDNA copy number.
(C) Insulin-stimulated glycogen synthesis (top insert, AKT-ser473 phosphorylation) in AdV-GFP and AdV-PARL() myotubes.
(D) Cysteine oxidation and (E) superoxide dismutase 2 (SOD2) activity in primary skeletal muscle cells derived from vastus lateralis muscle from lean-young
subjects, lean-insulin-resistant elderly subjects, and participants with T2DM. Lean-young myotubes were also transduced with (AdV)-GFP-empty cassette
and AdV-PARL-siRNA. n = 5.
(B–E) Data represent mean ± SEM. *, different to control; #, different to subjects with T2DM; ˆ, different to AdV-GFP. **, different to basal (non insulin stimulated).
p < 0.05.
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Muscle Insulin Resistance and Mitochondriaand PGC1a mRNA (Table S3; p < 0.05). No other significant
changes were observed, although there was a trend for elevated
PGC1b and OPA1 mRNA (Table S3). Together, these data
suggest that, in the progression of insulin resistance to T2DM,
the suppression of PARL and PGC1a parallel the impairment in
mitochondrial biogenesis.
Abnormal Fusion and Fission Protein Expression
in Primary Cultures of Human Muscle
To address the biological significance of reduced PARL protein
expression in human muscle, we first investigated mitochondrialCcontent and PARL protein expression and key proteins of mito-
chondrial energetics, fusion, and fission in primary human skel-
etal muscle cell model derived from vastus lateralis samples
from our clinical cohorts. Consistent with our mRNA analysis in
whole skeletal muscle, PARL mRNA (Figure S2A) and protein
levels (Figure 4A) were strikingly reduced in primary myotubes
derived from both T2DM and elderly subjects versus myotubes
from control subjects (p < 0.001). In mammals, the separation
of adjoined mitochondria by the fission process is chiefly
controlled by the cytosolic dynamin-related GTPase protein 1
(DRP1) that is recruited to the mitochondrial outer membraneell Metabolism 11, 412–426, May 5, 2010 ª2010 Elsevier Inc. 417
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Muscle Insulin Resistance and Mitochondriaby FIS1 (Stojanovski et al., 2004). FIS1 protein was lowest in
myotubes from T2DM individuals relative to myotubes from
elderly (p = 0.01), which, in turn, had lower FIS1 protein than in
controls (p = 0.005) (Figure 4A). DRP1 was not different between
the three cohorts (Figure 4A), possibly reflecting high cytosolic
abundance of DRP1 (Smirnova et al., 1998). The fusion of mito-
chondria requires MFN-1 and -2 to conjoin the ‘‘tethered’’ outer
membranes of juxtaposed mitochondria (Bach et al., 2003;
Pellegrini and Scorrano, 2007), whereas OPA1 unifies the inner
mitochondria membranes (Frezza et al., 2006). However, despite
lower protein content of MFN2 (p = 0.04) and OPA1 (Figure 4A;
p < 0.001) in myotubes from T2DM/elderly subjects compared
to those of control subjects, there was no significant difference
in MFN1 (Figure 4A) between the three groups. Similarly,
reducedMFN2 protein was observed in skeletal muscle samples
from obese humans (Bach et al., 2003). Thus, we show for the
first time that primary skeletal muscle cells derived from elderly
and T2DM subjects are characterized by low expression of
PARL andmitochondrial fusion and fission proteins (FIS1,MFN2,
and OPA1).
Low PARL protein expression was also associated with
impaired muscle energetics, with lower levels of mtDNA (Fig-
ure 4B) and CS protein (Figure 3A), and with impaired insulin-
stimulated glycogen synthesis (Figure 4C) in insulin-resistant
groups versus controls. However, we observed no difference
in PGC1a and TFAMmRNAs in subjects with T2DM (Figure S2A)
between the three cohorts. Despite the fact that sirtuin-1 (SIRT1)
activates PGC1a and mitochondrial biogenesis (Nemoto et al.,
2005; Rodgers et al., 2005), we observed a surprising upregula-
tion of SIRT1 mRNA (Figure S2A). However, SIRT1 protein was
lower in myotubes of T2DM participants (p = 0.04) and elderly
individuals (p = 0.03) relative to healthy controls (Figure 4A).
The mitochondrial fractions derived from myotubes of insulin-
resistant subjects (T2DM and elderly) demonstrated reduced
levels of DTT-reducible cysteines (measure of irreversible
cysteine oxidation; Figure 4D) and SOD2 activity (Figure 4E)
compared with controls. Together, these data show that myo-
tubes derived from insulin-resistant subjects are characterized
by low expression of PARL, FIS1, MFN2, and OPA1 protein;
reduced mitochondrial mass; nonoxidative glucose metabo-
lism; and elevated oxidative stress. Furthermore, the reduc-
tions in mitochondrial mass in elderly and T2DM myotubes
were independent of PGC1a, a known regulator of mitochondrial
mass.
PARL Protein Is a Determinant of Mitochondrial Mass
in Primary Human Muscle Cells
To investigate whether reduced PARL may be a cause, rather
than a consequence, of perturbed mitochondrial function in
human-derived muscle cells, we treated myotubes from the
lean-young cohort with AdV-PARL() siRNA and AdV-GFP
control shuttles. Myotubes transduced with AdV-PARL-siRNA
began to senesce (detachment of adherent cells) on day 7 of
differentiation (data not shown) in conjunction with lower OPA1
protein and elevated protein expression of the stress-induced,
proapoptotic protein BAX (Figure 5A), suggesting an elevated
rate of apoptosis (Frezza et al., 2006). No obvious morphological
defects were observed between the two types of myotubes
(decreased PARL versus normal PARL). Mitochondrial mass418 Cell Metabolism 11, 412–426, May 5, 2010 ª2010 Elsevier Inc.(p < 0.001) and mtDNA (p = 0.04) were both reduced in PARL
depleted myotubes (Figure 5B).
We next examined potential mechanisms by which PARL may
regulate mitochondrial biogenesis. Regulated intramembrane
proteolysis (RIP) is a signaling mechanism that involves the
generation of biologically active peptides from membrane-teth-
ered precursor proteins (Sı´k et al., 2004). PARL is cleaved by
RIP to generate a smaller 33 kDa inner mitochondrial membrane
protein termed PARL C-terminal product of b cleavage (PACT)
and, in turn, liberates a nuclear targeted 25 amino acid peptide
named PARL-b (Pb) (Sı´k et al., 2004). Fluorescent microscopy
analysis of healthy humanmyotubes transfected with a synthetic
Pb construct with a GFP (PbGFP) flag in the 50 position was used
to study Pb subcellular localization. Image overlay analysis
demonstrated a small fraction of Pb GFP localized within the
nucleus (white arrows), with the majority of PbGFP in the perinu-
clear region (pound sign), with mitochondria evenly distributed
throughout the myotubes (as indicated by Mitotracker Red;
Figure S2B, i–iv). It has been hypothesized that Pbmay mediate
mitochondria-to-nucleus crosstalk and regulate transcription
factor(s) to alter the expression of mitochondrial-specific genes
(Sı´k et al., 2004). We next treated myotubes with naive synthetic
Pbwith no GFP flag. Consistently, Pb (0.1 mg) robustly increased
the mRNA expression of PARL and genes involved in mitochon-
drial biogenesis (PGC1b and NRF1) and mitochondrial fusion
(MFN-1 and -2; Table S4 and OPA1 protein expression [Fig-
ure 6A]). No changes were observed in PGC1a, NRF2, and
RPLPO (internal control) mRNA (Table S4). Importantly, Pb
increased SIRT1 protein expression (Figures 6A and 6D) in con-
junction with elevatedmitochondrial biogenesis (Figure 6B), sug-
gesting a potential Pb-SIRT1 regulation of mitochondrial mass.
To confirm Pb effects on cellular energetics and SIRT1 protein
content, we treated RMS-13 human myoblasts with Pb GFP
plasmid containing the wild-type Pb (PbWT) sequence (amino
acids 53–77 of human PARL gene), Pb GFP plasmid with coded
mutation of the nuclear localization sequence (PbNLSM), the
backbone pEGFPN1 plasmid as control, and synthetic naive
Pb peptide (no GFP flag). Expression of PbWT and transfection
of naive Pb peptide increased cellular oxygen consumption
above that of PbNLSM (Figure 6E) and coincided with an
increase in SIRT1 protein (Figure 6D). Consistent with the ability
of SIRT1 to regulate mitochondrial mass (Lagouge et al., 2006),
PbWT in RMS13 cells robustly increased mitochondrial biogen-
esis (Figure 6C); however, the expression of PARL cDNA in
myoblasts did not alter mitochondrial mass (data not shown).
Conversely, expression of PARL in myoblasts increased cellular
oxygen consumption (Figure 6F). This suggests that Pb is able to
modulate mitochondrial energetics by increasing the transcrip-
tional machinery involved in regulating mitochondrial mass,
whereas PARL effect on cellular oxygen consumption may relate
to its effects on cristae remodeling or direct interaction with
OXPHOS protein(s).
PARL Protein Depletion in Myotubes Lowers Energetics
and Increases ROS Production
Consistent with lower mitochondrial mass, PARL() myotubes
displayed lower rates of oxygen consumption (Figure 5C;
p < 0.01), diminished COX II activity (Figure 5D; p < 0.01), and
lower rates of palmitate oxidation (Figure 5E; p = 0.04), indicating
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Figure 5. Mitochondrial Energetics in Human Myotubes with PARL()
(A and B) OPA1 and BAX protein expression (A) and mitochondrial mass using MitoTracker Green (B, i) and mtDNA copy number (B, ii) in primary skeletal muscle
cells from lean-young subjects transduced with AdV-GFP control and AdV-PARL-siRNA shuttles. Mitochondrial energetics.
(C–G) Oxygen consumption (C), cytochrome c oxidase 2 activity (D), lipid oxidation (E), hydrogen peroxide (H2O2) production (using 1 mmol/l of the H2O2-sensitive
fluorescent probe 1 carboxy-H2 [5-(and-6)-carboxy-2
0, 70-dichlorohydofluorescein diacetate] (DCFDA)) (F), and lipid peroxidation (TBA acid) (G) in lean-young
myotubes transduced with AdV-GFP control and AdV-PARL-siRNA shuttles.
(B–G) Data represent mean ± SEM. n = 5 in all groups. *, different to AdV-GFP control. p < 0.05.
Cell Metabolism
Muscle Insulin Resistance and Mitochondriaa reduction in oxidative capacity in PARL() myotubes. PARL()
myotubes were also characterized by impairments in nonoxida-
tive glucose disposal with reduced rates of insulin-stimulated
glycogen synthesis (Figure 4C) and AKT phosphorylation (Fig-
ure 4C, top). The effects on oxygen consumption and glucose
metabolism are similar to lower cellular respiration and glucose
oxidation in mammalian fibroblasts deficient in MFN2 protein
(Bach et al., 2003; Pellegrini and Scorrano, 2007). Analysis of
mitochondrial morphology by electron microscopy in PARL()
myotubes showed mitochondria to be uniformly distributed
throughout the myotubes (Figures 3E and 3F). Confocal micros-
copy reconfirmed distribution results with mitochondria con-
tained within reticulum networks (Figures 3G and 3H). Therefore,
PARL protein depletion in primary human muscle cells results in
reduced mitochondrial mass, impaired oxidative capacity, and
lower glycogen storage. However, PARL does not appear to
play a role in mitochondrial distribution in human muscle cells,
consistent with recent reports in other mammalian models
(Cipolat et al., 2006; Griparic et al., 2007). Therefore, PARL
appears to be involved in mitochondrial bioenergetics by modu-
lating cristae remodeling and/or participation in the regulation of
mitochondrial mass or cellular apoptosis.
Disturbance in mitochondrial cristae morphology can result in
elevated ROS production (Yu et al., 2006), as a significant pro-
portion of the oxidative phosphorylation machinery is embeddedCin the inner mitochondrial membrane. Analysis of ROS produc-
tion using carboxy-dichloro-fluorescence (Civitarese et al.,
2006) in PARL() myotubes revealed a 84% increase in H2O2
levels (p = 0.02) (Figure 5F), alongwith elevated lipid peroxidation
(Figure 5G), cysteine oxidation, and SOD2 activity (Figures 4D
and 4E; p < 0.05) relative to AdV-GFP. In addition, acute (3 hr)
exposure of PARL() myotubes to 20 mM glucose resulted
in a 96% increase in H2O2 production compared with basal
levels (p = 0.04; data not shown). Together, this indicates that
reduced PARL protein may explain a proportion of the elevated
oxidative stress observed in myotubes from elderly and T2DM
subjects.
In summary, we have shown that lowering PARL protein in
human muscle cells results in lower mitochondrial oxidative
capacity, coupled with reduced mitochondrial mass, increased
protein oxidation and ROS production, and impaired insulin
signaling—all known metabolic defects in T2DM and aging
(Conley et al., 2007; Imoto et al., 2006; Kelley et al., 2002; Morino
et al., 2005; Petersen et al., 2003, 2005; Ritov et al., 2005).
DISCUSSION
There is an abundance of indirect evidence demonstrating
diminished oxidative phosphorylation and lipid oxidation in
T2DM and aging (Civitarese et al., 2006; Kelley et al., 2002;ell Metabolism 11, 412–426, May 5, 2010 ª2010 Elsevier Inc. 419
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(A) OPA1 and SIRT1 protein expression (A) in human myotubes treated with 0.1 mg of naive Parl-b (Pb).
(B and C) Mitochondrial mass. Myotubes from lean-young subjects were transfected with (B) 0.1, 0.25, and 0.5 mg of naive Pb peptide (synthetic peptide without
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(D–F) (D) SIRT1 andGAPDHprotein expression and (E) cellular oxygen consumption analysis in RMS-13myoblasts were treatedwith T-control (D only), backbone
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Muscle Insulin Resistance and MitochondriaMorino et al., 2005; Petersen et al., 2003, 2005; Ritov et al., 2005;
Ukropcova et al., 2007). This has led to the widely held hypoth-
esis that mitochondrial dysfunction can lead to insulin resis-
tance. Elevated ROS production resulting from impaired mito-
chondrial metabolism and the accumulation of ectopic lipid
intermediates in skeletal muscle are linked to the activation of
serine kinases that inhibit insulin signaling (Adams et al., 2004;
Chavez and Summers, 2003; Yu et al., 2002). Early functional
studies postulated that, in combination with dyslipidemia, the
elevation of the lipid intermediates (i.e., diacylglycerol, ceram-
ides, and fatty acyl CoA) was driven by the inability of skeletal
muscle and mitochondria to appropriately shift between carbo-
hydrate and lipid as metabolic substrates, a defect referred to
as ‘‘metabolic inflexibility’’ (Kelley and Mandarino, 2000). Later,
in vitro studies demonstrated that increased PGC1a activity
elevated mitochondrial mass and lipid oxidation in isolated mito-
chondria and, in parallel, increased insulin-stimulated glucose
transport (Benton et al., 2008). Taken together, these data indi-
cated that mitochondrial abnormalities in insulin resistance can
result from either lower oxidative capacity—and therefore are
reflective of a functional impairment—or lower mitochondrial420 Cell Metabolism 11, 412–426, May 5, 2010 ª2010 Elsevier Inc.number, or a combination of both of these defects. Some studies
have questioned whether decreased mitochondrial markers
from insulin-resistant muscle are merely the result of less-active
muscle (Holloszy and Coyle, 1984; Terjung et al., 2002) and
therefore are reflective of the diminished energy requirement of
the muscle.
To address this, investigators have performed direct experi-
ments to determine the ability of isolated mitochondria from
healthy and insulin-resistant muscle to respire and synthesize
ATP with contradictory results. Hojlund et al. demonstrated
that the rates of state 3 respiration in isolated mitochondria are
lower in the skeletal muscle from subjects with T2DM relative
to obese controls (Mogensen et al., 2007). In accordance with
this study, a 35% lower ADP-stimulated respiration in muscle
fibers from subjects with type 2 diabetes has been described
(Phielix et al., 2008). Contradictory to these studies, Boushel
et al., using permeabilized human skeletal muscle fibers,
showed no difference in either NADH- or FADH2-linked respira-
tion in patients with T2DM compared to lean healthy subjects
(Boushel et al., 2007). In fact, metabolic control theory modeling
from 31P NMR spectroscopy experiments in resting skeletal
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Muscle Insulin Resistance and Mitochondriamuscle (the condition in which all the above studies were per-
formed) indicates that metabolic control lies exclusively at ATP
utilization and demand and not at sites of ATP production (Jene-
son et al., 2000). On the other hand, reduced demand for energy
supply does not exclude the coexistence of a functional abnor-
mality in mitochondria, and, in fact, the two could be related.
Given that reduced mitochondrial mass and function (lower
oxygen consumption, lower lipid oxidation, and elevated ROS
production) and impaired insulin signaling were observed in
PARL() muscle and myotubes, we propose that PARL protein,
insulin sensitivity status, andmitochondrial energetics (mass and
substrate oxidation) are directly linked and may account for
a portion of the energetic defects observed in insulin-resistant
muscle. Recent evidence in b cells demonstrates that regulation
of mitochondrial remodeling, assembly, and distribution are
important in modulating both mitochondrial number and ener-
getic status (Twig et al., 2008).
The mechanism that governs the transcriptional interplay
between mitochondrial function in insulin resistance is still
unclear. Although it is well accepted that PGC1a is one of the
chief regulators of mitochondrial biogenesis andmultiple studies
report lower PGC1a expression in the skeletal muscle of insulin-
resistant subjects with or without T2DM (Civitarese et al., 2006;
Mootha et al., 2003; Patti et al., 2003), lower PGC1amRNA levels
can result from chronic physical inactivity (Scarpulla, 2008), and
genetic models of PGC1a and PGC1b deletion do not show
muscle insulin resistance (Leone et al., 2005; Lin et al., 2004;
Sonoda et al., 2007). Similarly, global PARL knockout mice do
not develop T2DM, although failure to develop this phenotype
may relate to premature mortality, as PARL null mice die before
the end of the third month from cachexia (Cipolat et al., 2006).
Although,mice thatwere fedaHFD in thisstudyhadaprogressive
decline in glucose tolerance that was mirrored by reduced PARL
mRNA and mtDNA content in skeletal muscle, indicating the
suppressionofPARLmRNA trackswith lowermtDNAandawors-
ening of glucose tolerance. PPARd knockout mice develop both
mitochondrial dysfunction and T2DM, with mitochondrial abnor-
malities predating insulin resistance (Schuler et al., 2006). This
suggests that additional genetic ‘‘players’’ may be involved in
mitochondrial dysfunction and that insulin resistance can occur
in concert or independent of the PGC1 system. We propose
that an alternative pathway for the regulation of mitochondrial
mass may also include PARL-Pb. Reduced PARL protein would
be expected to result in reduced ability of Pb to provide a ‘‘retro-
grade’’ signal to the nucleus to stimulate mitochondrial mass via
SIRT1.
In most mammalian cells, mitochondria exist as ‘‘branched-
chain’’ reticulum networks that enable mitochondrial matrix
lumens to merge and the exchange of metabolites and mito-
chondrial nucleoids to occur (Civitarese and Ravussin, 2008).
Cells can then adapt to varying energy requirements by coupling
the mitochondrial electrochemical gradient between mitochon-
dria to distal cellular locations where ATP demand is highest
(Bach et al., 2003; Skulachev, 2001). This in situ ‘‘energy sens-
ing’’ (Amchenkova et al., 1988; Frazier et al., 2006) by mitochon-
dria is highly dependent on OPA1-mediated remodeling of the
cristae scaffold. OPA1 activity in the intermembrane mitochon-
drial space is controlled, in part, by the proteolytic cleavage of
OPA1 by PARL (Cipolat et al., 2006). Such activity can explainCour electron microscopy data showing altered mitochondrial
cristae in mCK-PARL() mice muscle, as well as the lower ener-
getic capacity and elevated ROS production in AdV-PARL()
myotubes. These data provide a rationale whereby mitochon-
drial cristae remodeling and mitochondrial function in skeletal
muscle are mediated, in part, by PARL, and lower PARL protein
content results in lower energetic efficiency of the cells and
contributes to cellular damage and aging (Figure 7).
Pb was able to upregulate fusion-specific expression (MFN1
and 2 and OPA1), which would favor the energy and metabolite
transfer between mitochondria (Civitarese et al., 2007) or clear-
ance of dysfunctional mitochondria (Twig et al., 2008). Recent
studies indicate that mitochondrial fusion and fission and
OPA1 levels constitute a quality control ‘‘checkpoint’’ that allows
for the sorting and elimination of functionally impaired mitochon-
dria by autophagic clearance (Twig et al., 2008). Given that mito-
chondrial mass is in constant flux and that steady-state levels of
mitochondrial mass are the product of mitochondrial biogenesis
and degradation (chiefly through macroautophagy), defects in
the regulators of this balance may contribute to mitochondrial
dysfunction in insulin resistance. A balanced level of mitochon-
drial autophagy is required to maintain the quality of cellular and
mitochondrial function (i.e., to eliminate the cell of damaged/
aging organelles) (Meijer and Codogno, 2007). Therefore, an
imbalance in fusion or fission or an overactive autophagy
machinery would be expected to result in altered mitochondrial
energetics or lower mitochondrial mass. This hypothesis is
consistent with the lower levels of PARL, OPA1, FIS1, and
MFN2 protein content measured in insulin-resistant myotubes
from this study and by others (Bach et al., 2003). Collectively,
these data further support our hypothesis that: (1) altered
PARL function may contribute to worsening mitochondrial func-
tion, mass, and insulin resistance and (2) changes in PARL
protein and the balance between fusion and fission may be
involved in changes in mitochondrial energetics and mass in
insulin resistance.
In summary, PARL shares commonalities with OPA1 by regu-
lating cristae shape (Cipolat et al., 2006; Frezza et al., 2006).
However, unlike bona fide fusion and fission proteins, PARL
has the ability to induce the transcription of both the fusion/
fission genes (including OPA1) and mitochondrial mass vis-a`-
vis Pb. In addition, the suppression of PARL mRNA tracks with
lower mtDNA and a worsening of glucose tolerance in mice fed
a HFD for 10 weeks. These studies demonstrate that PARL
mRNA suppression predates the suppression of FIS1, MFN2,
and OPA1 in insulin resistance. Taken together, this indicates
that lower PARL expression is an early defect altering mitochon-
drial function and insulin resistance in response to a metabolic
challenge. As insulin resistance worsens, declines in FIS1,
MFN2, and OPA1 protein probably occur at later stages (as
observed in insulin-resistant elderly and T2DM subjects),
contributing to a further decline in mitochondrial function. We
hypothesize that impaired PARL function is an important risk
factor for the development of insulin resistance in skeletal
muscle by decreasing mitochondrial mass and energetics and
increasing oxidative stress, thus contributing to impaired
glucose metabolism. As insulin resistance continues to develop,
mitochondrial function, oxidative damage, and PARL activity
may decline further, leading to a vicious cycle that eventuallyell Metabolism 11, 412–426, May 5, 2010 ª2010 Elsevier Inc. 421
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Figure 7. Overview of PARL Function and Steps that Contribute to the Formation of ROS and Insulin Resistance
PARL-mediated cristae remodeling results in maintenance of ‘‘normal’’ mitochondrial structure, oxidative capacity (both oxidative phosphorylation and b oxida-
tion), and insulin sensitivity. Improvements in mitochondrial energetics are further sustained by the ability of PARL-b (Pb) to induce SIRT-1 protein and mitochon-
drial biogenesis. Inhibition of PARL-mediated cristae remodeling results in damaged inner-membrane structure, loss of mtDNA, and reduced oxidative capacity.
Under hyperglycemic conditions, the increased production of NADH and FADH2, coupled with lower mitochondrial mass and a ‘‘structural leaky’’ inner
membrane, would favor electron transfer to oxygen creating reactive oxygen species (ROS) and damaging of the mitochondrial membrane. If mitochondrial
damage is not sufficiently compensated by increased Pb function and mitochondrial biogenesis, fusion/fission complementation of the mitochondrial genome,
and ROS defensemechanism, oxidative capacity would decline further, eventually leading to a vicious cycle of increasing muscle insulin resistance and oxidative
damage.
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ated diseases, including sarcopenia.EXPERIMENTAL PROCEDURES
Animal Care and Use
A colony of Psammomys obesus was maintained at Deakin University,
Geelong, Australia. Experimental animals were weaned at 4 weeks of age
and given a diet of standard laboratory chow, from which 12% of energy was
derived from fat, 63% from carbohydrate (CHO), and 25% from protein (Baras-
toc, Pakenham, Australia). Animals were housed in a temperature-controlled
room (22C ± 1C) with a 12-12 hr light-dark cycle (light 06:00–18:00). At
18 weeks of age, adult Psammomys obesus were euthanized, and selected
tissues were harvested immediately for protein extraction and PARL tissue
distribution analysis. All experimental animals andproceduresweremaintained
in accordance with the Code of Practice outlined by the National Health and
Medical Research Council (NHMRC) and were approved by the Deakin Univer-
sity AnimalWelfare Committee. For high-fat feeding studies,micewere housed
and maintained at Laboratory Animal Resources, Virginia Polytechnic Institute
and State University, Blacksburg, VA. All experimental protocols were
approved by the Institutional Animal Care and Use Committee at Virginia Tech.
Mice expressing the coxsackie/adenoviral receptor driven by the mus-
cle creatine kinase promoter (mCK-CAR) were generously provided by422 Cell Metabolism 11, 412–426, May 5, 2010 ª2010 Elsevier Inc.Drs. Nalbantoglu and Holland (McGill University). Heterozygous mice used in
this study (age 4 months) were housed under normal conditions (12 hr-12 hr
light/dark cycle) inmicroisolator units in the UCDenver Center for Comparative
Medicine, and all treatments and manipulations were approved by the UC
Denver Internal Animal Care and Use Committee.
In Vivo Knockdown of PARL Protein
Mice were placed on a high-fat ad libitum diet (HFD) (Research Diets, NJ,
#12344) for 2 weeks prior to the injection protocol. Under isoflurane anes-
thesia, mCK-CAR mice were injected with AdV-PARL-siRNA() (1 3 108
plaque forming units [pfu] in 25 ml) in each lobe of their left gastrocnemius
muscle and in the tibialis/extensor digitorum longus (TA/EDL) muscle group.
An additional injection of AdV-GFP (1 3 108 pfu in 25 ml) was delivered in
each lobe of the gastrocnemius muscle and the TA/EDL muscle group of the
contralateral leg. All experiments were performed at 7 days posttransduction
with mice remaining on a HFD during this period. An additional set of mCK-
CAR mice were injected with an equivalent volume of the saline vehicle
in the left gastrocnemius muscle, whereas the contralateral leg was left
untreated. Following injections, mice were allowed to recover and were
maintained in a biohazard-specific pathogen-free barrier facility. The mice
were then fed an ad libitum high-fat diet (Research Diets, NJ, #D12344) for
7 days, after which the muscles were collected under isoflurane anesthesia
and flash frozen in liquid nitrogen or placed in a fixative solution (6.25%Glutar-
aldehyde in 0.1MSodiumCacodylate Buffer [pH 7.4]) for electronmicroscopic
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15 min prior to euthanasia and tissue collection.
Using mitochondrial DNA and citrate synthase activity as endpoint
measures, we found no difference between AdV-GFP, saline, and untreated
controls (data not shown). Therefore, only AdV-PARL() and AdV-GFP trans-
duced muscle data is shown in manuscript.
Human Subjects
Eleven young (18–29 years), 11 elderly (60–84 years), and 32 subjects with type
2 diabetes mellitus (40–67 years) were recruited into this study. All subjects
underwent complete physical examination, routine medical laboratory tests,
and anthropometry. Nonsmoking and healthy young individuals (5F/6M)
and elderly subjects (5F/6M) with a BMI 20–25 kg/m2 and fasting glucose
of < 110 mg/dl were included. All young and elderly subjects were sedentary
and matched for physical activity by activity index questionnaire. Subjects
with type 2 diabetes diagnosed at least 6 months earlier were evaluated. All
subjects had been previously maintained on dietary therapy only and did not
use insulin or thiazolidinediones. They were required to have a fasting plasma
glucose ofR 125 mg/dl but of < 170 mg/dl at time of screening. Subjects on
medications known to affect glucose metabolism were excluded. Physical
activity in all subjects was determined by questionnaire, with participants
reporting less than three times per week of aerobic exercise. The Internal
Review Board of the Pennington Biomedical Research Center approved the
protocol, and subjects provided written informed consent.
Skeletal Muscle Cell Culture
Vastus lateralis muscle biopsy (100 mg) was obtained from a subset of
the clinical cohort. Five healthy and young sedentary subjects (age 24.2 ±
0.2 years old; BMI 23.7 ± 0.5; percent body fat 19.9% ± 3%; fasting glucose
concentration 90 ± 3 mg/dl and fasting plasma insulin 4.0 ± 0.4 mU/ml), five
elderly subjects (age 65.1 ± 3 years old; BMI 23.8 ± 0.7; percent body fat
21.7%± 2.8%; fasting glucose concentration 96 ± 3mg/dl, and fasting plasma
insulin 6.1 ± 1 mU/ml), and five individuals with T2DM (age 51.8 ± 3 years
old; BMI 24.2 ± 0.5; percent body fat 26%± 2%; fasting glucose concentration
139 ± 17 mg/dl, and fasting plasma insulin 31 ± 5 mU/ml). All subjects were
male. Satellite cells were isolated as previously described (Civitarese et al.,
2006; Ukropcova et al., 2005). Cells were seeded into 12-well and 6-well plates
at a density of 203 103 cells per cm2 and grown at 37C in a humidified atmo-
sphere of 5% CO2. All myoblasts were differentiated into myotubes as previ-
ously described (Civitarese et al., 2006). In selected wells, myotubes were
transduced with either AdV-PARL-siRNA (CCU AUC CUA UAA GGA GUC
UCA UAA A) or AdV-GFP control shuttle using a low dose (4 3 106 pfu) in
saline. Saline-treated cells were used as additional negative controls. All
metabolic assays were performed 6 days posttransduction. Human RMS-13
myogenic and stable cell line were purchased from ATCC.
Vector Constructs
PARL cDNA clone was inserted into the pcDNA 3.1(+) vector (Invitrogen, Inc.)
under the control of the CMV promoter. For Pb studies, the backbone vector
used was a control GFP construct-pEGFPN1 (Invitrogen, Inc.). Using this
plasmid, the wild-type Pb (PbWT) sequence (amino acids 53–77 of human
PARL) was cloned upstream of the GFP flag. A coding methionine (in the
context of a kozak sequence) was added upstream of the Pb sequence to
ensure initiation of translation from this site. To prevent translation of GFP
alone (a consequence of ‘‘leaky’’ scanning by the ribosome), the codingmethi-
onine of the GFP open reading frame was mutated to isoleucine. To create the
PbNLSM, the amino acids of PbWT 54 and 55 and amino acids 58 and 59 (both
human PARL gene) were substituted from arginine and lysine to glycine and
serine. A similar PbNLSM was used by Sik et al. (2004), with two doublets
changed (54RK55 to 54TS55 and 58RK59 to 58TS59).
Mitochondrial Content and Enzyme Activity Assay
For quantification of mitochondrial content, we used mtDNA and Mitotracker
Green probe (Molecular Probes) as previously described (Civitarese et al.,
2006). Mitotracker Green probe preferentially accumulates in mitochondria
and provides an accurate assessment of mitochondrial mass. Cells were
washed with PBS and incubated at 37C for 30 min with 100 nM MitoTracker
Green FM (Molecular Probes). Cells were harvested using trypsin/EDTA andCresuspended in PBS. Fluorescence intensity was detected with excitation
and emission wave lengths of 490 and 516 hm, respectively, and values
were corrected for total protein (mg/ml). Citrate synthase, cytochrome c
oxidase, and b-HAD activities were determined spectrophotometrically from
cell homogenates using previously describedmethods (Civitarese et al., 2006).
Myotube Oxygen Consumption
Oxygen consumption in primary human myotubes was measured using a self-
referencing microelectrode system (MacLellan et al., 2005). Myotubes,
cultured in a 6 cm2 dish, were suspended in Earle’s basic salt solution
(117 mmol/l NaCl, 5.4 KCl, 1.5 CaCl2, 0.8 MgSO4, 0.9 mmol/l NaH2PO4,
10 mmol/l HEPES, and 5.6 mmol/l glucose) and housed within an insulated
Faraday box and maintained at 37C. The oxygen microelectrode was oscil-
lated at a frequency of 0.3 Hz to collect alternating oxygen flux and reference
measurements. Total cellular oxygen consumption was determined for a
5 min period, and values were corrected using mg protein.
For PARL-b experiments in RMS-13 cells, a Seahorse Bioscience XF24
instrument was used to measure the rate of change of dissolved O2 and pH
in medium immediately surrounding cell culture in 24-well plates. Measure-
ments were performed using a cartridge in which 24 optical fluorescent O2
and pH sensors are configured as individual well ‘‘plungers.’’ For measure-
ments of rates, the plungers gently descended into the wells, forming a
chamber that entraps the cells in 5 ml volume. O2 concentration and pH
were measured for 2 min. The rates of O2 consumption and extracellular acid-
ification were obtained from the slopes of concentration changes versus time.
For preparation of the cell plate for assay with the XF24 instrument, 1 ml
of Krebs-Henseleit buffer lacking bicarbonate (111 mM NaCl, 4.7 mM KCl,
2.0 mM MgSO4, 1.2 mM Na2HPO4, 0.24 mM MgCl2, and 5 mM Sodium Pyru-
vate) warmed to 37C was added to each well containing 0.25 3 106 RMS-13
myoblasts.
Glycogen Synthesis
The rate of total glycogen synthesis was determined inmyotubesmaintained in
differentiation medium for 5 days by measuring the incorporation of D-[U-14C]
glucose into glycogen. Cells were incubated in 1 ml of experimental medium
(136 mM NaCl, 4.7 mM KCl, 1.25 mM MgSO47H2O, 1.2 mM CaCl/2H2O, and
20 mM HEPES [pH 7.4]), with and without insulin, containing D-[14C]glucose
(1.25 mCi/ml, final concentration). Cells were lysed by adding 200 ml 20%
(wt/vol) potassium hydroxide and partially neutralized with 200 ml 1 M hydro-
chloric acid. The cell extracts were then transferred to Eppendorf tubes and
glycogen extracted by ethanol precipitation after the addition of 12mg/ml (final
concentration) carrier glycogen. Radioactivity incorporated into glycogen was
determined by scintillation counting.
Electron Microscopy
mCK-CARmuscle specimenswere fixed for 4 hr by immersion in 2%glutarald-
heyde in 0.1 M phosphate buffer (pH 7.4) at 4C –6C. Bioptic specimens were
then fixed in 1%osmium tetroxide and embedded in an Epon-Aralditemixture.
Semi-thin sections (2 mm) were stained with toluidine blue, and thin sections
obtained with an MT-X ultratome (RMC, Tucson, Arizona) were stained with
lead citrate and examined with a CM10 transmission electron microscope
(Philips, Eindhoven, Netherlands). Scanning electron microscopy analysis of
AdV-PARL() cells and AdV-GFP-transduced myotubes were performed by
Quantomix Ltd. (Israel) as previously described (Thiberge et al., 2004).
Confocal Microscopy
In 12-well collagen-treated plates, fully differentiated myotubes were washed
twice in PBS, and cells were incubated at 37C for 30 min with 100 nM Mito-
Tracker Green FM (Molecular Probes). Myotubes were washed twice with
PBS, and a single in-focus optical section was acquired using a confocal
microscope (Nikon Eclipse TE2000-U) with a 340 air objective, as previously
described (Civitarese et al., 2006).
Statistical Analysis
Group means were compared by analysis of variance. In young, lean, and
elderly subjects, age, sex, BMI, percent body fat, insulin sensitivity (HOMA-
IR), fasting plasma insulin and glucose, plasma fatty acids, PARL, OPA1,
MFN1/2, PGC1a/b mRNA, TCAD mRNA, mtTFA mRNA, citrate synthase,ell Metabolism 11, 412–426, May 5, 2010 ª2010 Elsevier Inc. 423
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Muscle Insulin Resistance and Mitochondriaand b-HAD enzyme activity were entered in stepwise regression models to
assess their contribution to the interindividual variability of mtDNA copy
number and energy expenditure. Pearson correlation coefficients were calcu-
lated to determine the relationship between selected variables within each
group. All data are presented as means ± SEM. p values < 0.05 were consid-
ered statistically significant.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five tables, and two figures and can be found with this article online at
doi:10.1016/j.cmet.2010.04.004.
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